Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Duncan Richards

Prof. Duncan Richards

Climax Professor of Clinical Therapeutics and Director of the Oxford Clinical Trial Research Unit.

Recently appointed to the newly created Climax Professorship of Clinical Therapeutics, Professor Duncan Richards will establish a new Centre for Clinical Therapeutics based at the Botnar Research Centre and St Hilda’s. The Centre, under his leadership, will work with a diverse range of Oxford biomedical researchers and more widely with the pharmaceutical, biotechnology and diagnostics industries, in order to drive new drug treatments through decision-making in early phase clinical trials.

Prior to taking up this role in Oxford in 2019, Duncan spent nearly 20 years working for GSK in a number of clinical development roles, ranging from first in human to file and launch. Latterly Duncan was head of Clinical Pharmacology and Experimental Medicine for GSK Research and Director of GSK’s phase 1 and experimental medicine unit in Cambridge (CUC). He is closely involved in the development of a new Clinical Research Facility network in Oxford. 

Externally Duncan is a member of the UK COVID-19 Therapeutics Advisory Panel (UK-CTAP).